Article
Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily.
Human vaccines & immunotherapeutics - 3 Aug 2017
Capra Giuseppina, Giovannelli Lucia, Matranga Domenica, Bellavia Carmelina, Guarneri Maria Francesca, Fasciana Teresa, Scaduto Giovanna, Firenze Alberto, Vassiliadis Alessandra, Perino Antonio
Abstract excerpt
While bivalent and quadrivalent HPV vaccines have been used for about 10 years, a nonavalent vaccine against HPV types 6/11/16/18/31/33/45/52 and 58 has been recently approved by FDA and EMA and is now commercially available. The objective of our study was to evaluate the potential impact of the nonavalent vaccine on HPV infection and related low- and high-grade squamous intraepithelial lesions (LSIL, HSIL),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
